Luo C - Search Results

1

VP-1 quasispecies in human infection with polyomavirus BK.

Luo C, Hirsch HH, Kant J, Randhawa P. Luo C, et al. J Med Virol. 2012 Jan;84(1):152-61. doi: 10.1002/jmv.22147. Epub 2011 Nov 3. J Med Virol. 2012. PMID: 22052529 Free PMC article.

2

Genotyping schemes for polyomavirus BK, using gene-specific phylogenetic trees and single nucleotide polymorphism analysis.

Luo C, Bueno M, Kant J, Martinson J, Randhawa P. Luo C, et al. J Virol. 2009 Mar;83(5):2285-97. doi: 10.1128/JVI.02180-08. Epub 2008 Dec 24. J Virol. 2009. PMID: 19109389 Free PMC article.

3

Biologic diversity of polyomavirus BK genomic sequences: Implications for molecular diagnostic laboratories.

Luo C, Bueno M, Kant J, Randhawa P. Luo C, et al. J Med Virol. 2008 Oct;80(10):1850-7. doi: 10.1002/jmv.21281. J Med Virol. 2008. PMID: 18712842 Free PMC article.

4

Impact of genomic sequence variability on quantitative PCR assays for diagnosis of polyomavirus BK infection.

Randhawa P, Kant J, Shapiro R, Tan H, Basu A, Luo C. Randhawa P, et al. Among authors: luo c. J Clin Microbiol. 2011 Dec;49(12):4072-6. doi: 10.1128/JCM.01230-11. Epub 2011 Sep 28. J Clin Microbiol. 2011. PMID: 21956980 Free PMC article.

5

Validation of BKV large T-antigen ATP-binding site as a target for drug discovery.

Zeng G, Bueno M, Camachos CJ, Ramaswami B, Luo C, Randhawa P. Zeng G, et al. Among authors: luo c. Antiviral Res. 2009 Feb;81(2):184-7. doi: 10.1016/j.antiviral.2008.11.004. Epub 2008 Dec 11. Antiviral Res. 2009. PMID: 19084558 Free PMC article.

6

The polyomavirus BK large T-antigen-derived peptide elicits an HLA-DR promiscuous and polyfunctional CD4+ T-cell response.

Ramaswami B, Popescu I, Macedo C, Luo C, Shapiro R, Metes D, Chalasani G, Randhawa PS. Ramaswami B, et al. Among authors: luo c. Clin Vaccine Immunol. 2011 May;18(5):815-24. doi: 10.1128/CVI.00487-10. Epub 2011 Mar 2. Clin Vaccine Immunol. 2011. PMID: 21367979 Free PMC article.

7

BK virus-associated urinary bladder carcinoma in transplant recipients: report of 2 cases, review of the literature, and proposed pathogenetic model.

Alexiev BA, Randhawa P, Vazquez Martul E, Zeng G, Luo C, Ramos E, Drachenberg CB, Papadimitriou JC. Alexiev BA, et al. Among authors: luo c. Hum Pathol. 2013 May;44(5):908-17. doi: 10.1016/j.humpath.2012.09.019. Epub 2013 Jan 11. Hum Pathol. 2013. PMID: 23317548 Review.

8

How Authoritative Media and Personal Social Media Influence Policy Compliance Through Trust in Government and Risk Perception: Quantitative Cross-Sectional Survey Study.

Zhang H, Yang C, Deng X, Luo C. Zhang H, et al. Among authors: luo c. J Med Internet Res. 2025 Jan 20;27:e64940. doi: 10.2196/64940. J Med Internet Res. 2025. PMID: 39832177

9

Evaluation of the safety profile of amivantamab based on real-world evidence: a call to vigilance.

Liao Z, Luo C, Huang Y, Jiang Z, Wei H, Wang Y. Liao Z, et al. Among authors: luo c. Expert Opin Drug Saf. 2025 Jan 19. doi: 10.1080/14740338.2025.2456167. Online ahead of print. Expert Opin Drug Saf. 2025. PMID: 39829078

10

Intracellular trafficking of lipid nanoparticles is hindered by cholesterol.

Luo C, Li Y, Liu H, He J, Yang X, Zhao E, Zi G, Liu L, Hong Y, Wang H, Li T, Yang Z, Wang R, Xu Y, Peng B. Luo C, et al. Int J Pharm. 2025 Jan 16;671:125240. doi: 10.1016/j.ijpharm.2025.125240. Online ahead of print. Int J Pharm. 2025. PMID: 39826779

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,565 results

Search Page

Filters